These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 31921109)

  • 1. Understanding and Modulating Immunity With Cell Reprogramming.
    Pires CF; Rosa FF; Kurochkin I; Pereira CF
    Front Immunol; 2019; 10():2809. PubMed ID: 31921109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Fate Reprogramming in the Era of Cancer Immunotherapy.
    Zimmermannova O; Caiado I; Ferreira AG; Pereira CF
    Front Immunol; 2021; 12():714822. PubMed ID: 34367185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors.
    Rosa FF; Pires CF; Zimmermannova O; Pereira CF
    Bio Protoc; 2020 May; 10(10):e3619. PubMed ID: 33659292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.
    Rosa FF; Pires CF; Kurochkin I; Halitzki E; Zahan T; Arh N; Zimmermannová O; Ferreira AG; Li H; Karlsson S; Scheding S; Pereira CF
    Sci Immunol; 2022 Mar; 7(69):eabg5539. PubMed ID: 35245086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct reprogramming of fibroblasts into antigen-presenting dendritic cells.
    Rosa FF; Pires CF; Kurochkin I; Ferreira AG; Gomes AM; Palma LG; Shaiv K; Solanas L; Azenha C; Papatsenko D; Schulz O; Reis e Sousa C; Pereira CF
    Sci Immunol; 2018 Dec; 3(30):. PubMed ID: 30530727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Cellular Reprogramming: The Next Generation.
    Srivastava D; DeWitt N
    Cell; 2016 Sep; 166(6):1386-1396. PubMed ID: 27610565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular roadblocks for cellular reprogramming.
    Vierbuchen T; Wernig M
    Mol Cell; 2012 Sep; 47(6):827-38. PubMed ID: 23020854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells.
    Sontag S; Förster M; Qin J; Wanek P; Mitzka S; Schüler HM; Koschmieder S; Rose-John S; Seré K; Zenke M
    Stem Cells; 2017 Apr; 35(4):898-908. PubMed ID: 28090699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the reprogramming potential of B cells and comprehending its clinical and therapeutic perspective.
    Rani R; Nayak M; Nayak B
    Transpl Immunol; 2023 Jun; 78():101804. PubMed ID: 36921730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Past, Present, and Future of Direct Cell Reprogramming.
    Ahlenius H
    Cell Reprogram; 2022 Oct; 24(5):205-211. PubMed ID: 36219713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2-mediated metabolic reprogramming of tolerogenic dendritic cells is protective against aplastic anemia.
    Wei HJ; Gupta A; Kao WM; Almudallal O; Letterio JJ; Pareek TK
    J Autoimmun; 2018 Nov; 94():33-44. PubMed ID: 30025621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional reprogramming of CD11b+Esam(hi) dendritic cell identity and function by loss of Runx3.
    Dicken J; Mildner A; Leshkowitz D; Touw IP; Hantisteanu S; Jung S; Groner Y
    PLoS One; 2013; 8(10):e77490. PubMed ID: 24204843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct reprogramming into desired cell types by defined factors.
    Ieda M
    Keio J Med; 2013; 62(3):74-82. PubMed ID: 23801083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological computational approaches: new hopes to improve (re)programming robustness, regenerative medicine and cancer therapeutics.
    Ebrahimi B
    Differentiation; 2016; 92(1-2):35-40. PubMed ID: 27056282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell development-History, advances, and open questions.
    Puhr S; Lee J; Zvezdova E; Zhou YJ; Liu K
    Semin Immunol; 2015 Dec; 27(6):388-96. PubMed ID: 27040276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct reprogramming with SOX factors: masters of cell fate.
    Julian LM; McDonald AC; Stanford WL
    Curr Opin Genet Dev; 2017 Oct; 46():24-36. PubMed ID: 28662445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transflammation: How Innate Immune Activation and Free Radicals Drive Nuclear Reprogramming.
    Meng S; Chanda P; Thandavarayan RA; Cooke JP
    Antioxid Redox Signal; 2018 Jul; 29(2):205-218. PubMed ID: 29634341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
    Hoang T; Lambert JA; Martin R
    Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.